Superworth

Vistagen Therapeutics EPS VTGN

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$1.67
Latest quarter, Q1 FY27
−$0.30
Fiscal year 2026
−$1.84

Vistagen Therapeutics' earnings per share was −$1.67 over the twelve months to Jun 30, 2026.

In its latest quarter, Q1 FY27, it was −$0.30.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2026−$1.84n/a
FY2025−$1.66n/a
FY2024−$2.13n/a
FY2021−$11.70n/a
FY2020−$15.30n/a
FY2019−$27.30n/a
FY2018−$37.50n/a
FY2017−$47.70n/a
FY2016−$926.40n/a
FY2015−$327.60n/a
FY2014−$114.60n/a
FY2013−$762.00n/a
FY2012−$498.00n/a
FY2011−$1086.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q1 FY27−$0.30n/a−$1.67
Q4 FY26−$0.38n/a−$1.84
Q3 FY26−$0.45n/a−$1.89
Q2 FY26−$0.54n/a−$1.90
Q1 FY26−$0.47n/a−$1.78
Q4 FY25−$0.43n/a−$1.66
Q3 FY25−$0.46n/a−$1.54
Q2 FY25−$0.42n/a−$1.30
Q1 FY25−$0.35n/a−$1.54
Q4 FY24−$0.31n/a−$2.13
Q3 FY24−$0.22n/an/a
Q2 FY24−$0.66n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Vistagen Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
VTGNVistagen Therapeutics−$1.67
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Vistagen Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.